GENinCode (LON:GENI – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported GBX (0.38) EPS for the quarter, Digital Look Earnings reports. GENinCode had a negative return on equity of 481.34% and a negative net margin of 202.42%.
GENinCode Stock Performance
Shares of LON:GENI traded up GBX 0.04 during midday trading on Thursday, reaching GBX 0.73. 2,103,826 shares of the company traded hands, compared to its average volume of 5,110,390. GENinCode has a 12 month low of GBX 0.64 and a 12 month high of GBX 4.90. The firm’s fifty day moving average price is GBX 0.88 and its two-hundred day moving average price is GBX 0.98. The company has a quick ratio of 15.88, a current ratio of 2.22 and a debt-to-equity ratio of 4.75. The firm has a market capitalization of £5.53 million, a price-to-earnings ratio of -0.35 and a beta of 0.59.
About GENinCode
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Featured Articles
- Five stocks we like better than GENinCode
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
